Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men
Launched by UNIVERSITY OF SOUTHERN DENMARK · Sep 27, 2023
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying how taking collagen peptides (a type of protein) after resistance training can affect body composition and muscle strength in untrained overweight men aged 30 to 60. The researchers want to find out if combining collagen peptides with exercise improves lean body mass, muscle strength, and fat levels better than just exercise alone. Participants will be part of a controlled study, meaning some will receive the collagen and others won't, allowing for a fair comparison of results.
To join the study, men must be between 30 and 60 years old, have a body fat percentage higher than 25%, and have had a stable weight and eating habits for the last three months. However, those who exercise regularly, have certain health conditions, or have experienced serious health issues in the last five years may not be eligible. Participants can expect to engage in a structured resistance training program while receiving either the collagen peptides or a placebo. This trial aims to provide insights into how dietary supplements might enhance the benefits of exercise, making it an important opportunity for eligible men looking to improve their health and fitness.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male, between 30 and 60 years of age
- • Fat mass \>25 % as measured by bioelectrical impedance analysis
- • Stable weight (±5 %) and eating behaviour within the last 3 months.
- • Signed informed consent
- Exclusion Criteria:
- • Regular physical activity \>60 min / week
- * Stabile or progressive diseases/conditions (including medication) contraindicating or disabling participation in intensive exercise training and/or with potential to affect training adaptation beyond normal variation. For example:
- • Contraindications against physical stress corresponding guidelines of American College of Sports Medicine (ACSM)
- • Subjective symptoms during exercise (e.g., unusual physical exhaustion, dyspnoea, nausea)
- • Moderate to severe mobility limitation (i.e., due to rheumatic disease)
- • Diagnosis of cancer within the last 5 years
- • Diabetes mellitus I and II uncontrolled arterial hypertension (systolic blood pressure \>155 for mmHg and/or diastolic blood pressure \>94 mm Hg; mild hypertension under resting condition will be allowed but such participants will be recommended to consult their general practitioner).
- • Conditions contraindicating the supplementation protocol.
- • Contraindications against nutritional or ergogenic supplements
- • Allergy/aversion against animal protein
- • Liver or kidney diseases with a non-permission to ingest certain concentrations of protein.
About University Of Southern Denmark
The University of Southern Denmark (SDU) is a prominent research institution dedicated to advancing knowledge and innovation across various fields, including health sciences. As a clinical trial sponsor, SDU is committed to conducting rigorous and ethically sound research aimed at improving patient outcomes and informing clinical practices. Leveraging its multidisciplinary expertise and state-of-the-art facilities, SDU collaborates with healthcare professionals, industry partners, and regulatory bodies to develop and execute clinical trials that adhere to the highest standards of scientific integrity and compliance. Through its research initiatives, SDU seeks to contribute to the global body of medical knowledge and enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported